注册并分享邀请链接,可获得视频播放与邀请奖励。

Wall St Engine
@wallstengine
Fast, accurate, consistent stock market news, earnings highlights & more. By Brillinsight. Not financial advice.
加入 March 2022
1000 正在关注    223.7K 粉丝
INSULET $PODD Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $842M (Est. $833M) 🟢; +19.2% YoY 🔹 Adj. EPS: $1.99 (Est. $1.59) 🟢; +59.9% YoY 🔹 Adjusted EBITDA: $233.7M (Est. $196M) 🟢 🔹 Adjusted Oper Income: $185.2M (Est. $151M) 🟢 FY26 Guide: 🔹 U.S. Omnipod: +17.5%-+18.5% 🔹 International Omnipod: +32%-+33% 🔹 Total Omnipod: +21.5%-+22.5% 🔹 Drug Delivery: ~(40)% 🔹 Total Revenue: +21%-+22% 🔹 Adjusted Operating Margin: ~+150 bps YoY 🔹 Adjusted EPS Growth: >30% Segment Net Revenue: 🔹 U.S. Omnipod: $570.4M; +14.7% YoY 🔹 International Omnipod: $266.2M; +31.7% YoY 🔹 Drug Delivery: $5.5M; -22.7% YoY Announcements: 🔹 Omnipod Discover: >35,000 users; 5,000 healthcare professionals 🔹 Omnipod 5 Data: >384,000 people across 17 countries Other Q3 Metrics: 🔹 Gross Margin: 75.1% GAAP; 74.2% adjusted 🔹 Total Omnipod Revenue: $836.6M; +19.7% YoY Capital Return: 🔹 Share Repurchase Authorization: $1B 🔹 Q4 Repurchases: ~$400M Comments: 🔸 “Our team delivered a strong quarter, with revenue growth of nearly 20% and significant margin expansion”
显示更多